| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 2020 |
| 1 | TRIAMCINOLONE ACETONIDE | 23 |
| 2 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 23 |
| 3 | TACROLIMUS | 21 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 21 |
| 5 | TACROLIMUS OINTMENT 0.1% | 21 |
| 6 | ALBUTEROL SULFATE | 19 |
| 7 | HYDROCORTISONE | 19 |
| 8 | CETIRIZINE HYDROCHLORIDE | 18 |
| 9 | HYDROCORTISONE ACETATE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORINE | 1 | 0.0159 |
| 1 | COLLOIDAL SILVER | 1 | 0.0116 |
| 2 | CLOBETASOL PROPIONATE CREAM USP, 0.05% | 1 | 0.0101 |
| 3 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 4 | PYRITHIONE ZINC | 3 | 0.0049 |
| 5 | DUPILUMAB | 2020 | 0.0039 |
| 6 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | 1 | 0.0026 |
| 7 | LEBRIKIZUMAB-LBKZ | 4 | 0.0018 |
| 8 | TRALOKINUMAB-LDRM | 10 | 0.0015 |
| 9 | PIMECROLIMUS | 2 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2020 |
| 1 | Corticosteroid [EPC] | 75 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 3 | Interleukin-13 Antagonist [EPC] | 14 |
| 4 | Janus Kinase Inhibitor [EPC] | 13 |
| 5 | Provitamin D2 Compound [EPC] | 13 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 10 |
| 7 | Proton Pump Inhibitor [EPC] | 9 |
| 8 | Benzodiazepine [EPC] | 8 |
| 9 | Phosphodiesterase 4 Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2020 | 0.0039 |
| 1 | Interleukin-13 Antagonist [EPC] | 14 | 0.0021 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 3 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 4 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 5 | Interleukin-31 Receptor alpha Antagonist [EPC] | 4 | 0.0003 |
| 6 | Leukotriene Receptor Antagonist [EPC] | 7 | 0.0002 |
| 7 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 8 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 9 | Janus Kinase Inhibitor [EPC] | 13 | 0.0001 |